3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Terminated
2
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
4
Prostatic Neoplasms
3
Neoplasms
3
Neoplasm Metastasis
3
Breast Neoplasms
3
Advanced Solid Tumor
3
Pancreatic Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Hypoxia
2
Advanced Solid Tumors
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pelvic Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mesothelioma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Monocytic, Acute
1
Leukemia, Biphenotypic, Acute
1
Interventions
Injections
2
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
2
alovudine
1
Nitroglycerin
1
Magnetic Resonance Spectroscopy
1
Exercise
1
Drug Therapy
1
Bacterial Load
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Hypoxia
×
Injections
×
Clear all
NCT02233387
2019-03-08
HX4-cervix
Maastricht Radiation Oncology
Phase 2
Terminated
4 enrolled
NCT02584400
2019-03-08
HX4 SD
Maastricht Radiation Oncology
Phase 2
Terminated
1 enrolled